72例肺腺鳞癌临床病理特点和预后因素分析

BACKGROUND AND OBJECTIVE: Adenosquamous carcinoma (ASC) is a rare subtype of lung cancer, it is mixed glandular and squamous cell carcinoma with a more aggressive behavior and poor prognosis than the other histologic subtypes. The aim of the study was to explore the clinicopathological characteristi...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2016
Materias:
肺鳞癌专题
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973411/
https://www.ncbi.nlm.nih.gov/pubmed/27760593
http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.03
_version_ 1783326625093386240
collection PubMed
description BACKGROUND AND OBJECTIVE: Adenosquamous carcinoma (ASC) is a rare subtype of lung cancer, it is mixed glandular and squamous cell carcinoma with a more aggressive behavior and poor prognosis than the other histologic subtypes. The aim of the study was to explore the clinicopathological characteristics and prognostic factors of ASC. METHODS: A total of 72 patients were enrolled. We investigated clinicalpathological features and prognostic factors retrospectively. RESULTS: The overall 72 ASC patients' median age was 34.7 months, 5-year survival rate was 14.9%. The influence of tumor size, M stage, and N stage, gene mutation and surgery on the prognosis of patients show statistical significance. CONCLUSION: ASC is characterized by both histologic aggressiveness and adverse prognosis. We suggest the comprehensive therapy based on surgery, and given small molecule tyrosine kinase inhibitors (TKIs) treatment may prolong patients' overall survival.
format Online
Article
Text
id pubmed-5973411
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59734112018-07-06 72例肺腺鳞癌临床病理特点和预后因素分析 Zhongguo Fei Ai Za Zhi 肺鳞癌专题 BACKGROUND AND OBJECTIVE: Adenosquamous carcinoma (ASC) is a rare subtype of lung cancer, it is mixed glandular and squamous cell carcinoma with a more aggressive behavior and poor prognosis than the other histologic subtypes. The aim of the study was to explore the clinicopathological characteristics and prognostic factors of ASC. METHODS: A total of 72 patients were enrolled. We investigated clinicalpathological features and prognostic factors retrospectively. RESULTS: The overall 72 ASC patients' median age was 34.7 months, 5-year survival rate was 14.9%. The influence of tumor size, M stage, and N stage, gene mutation and surgery on the prognosis of patients show statistical significance. CONCLUSION: ASC is characterized by both histologic aggressiveness and adverse prognosis. We suggest the comprehensive therapy based on surgery, and given small molecule tyrosine kinase inhibitors (TKIs) treatment may prolong patients' overall survival. 中国肺癌杂志编辑部 2016-10-20 /pmc/articles/PMC5973411/ /pubmed/27760593 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.03 Text en 版权所有©《中国肺癌杂志》编辑部2016 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 肺鳞癌专题
72例肺腺鳞癌临床病理特点和预后因素分析
title 72例肺腺鳞癌临床病理特点和预后因素分析
title_full 72例肺腺鳞癌临床病理特点和预后因素分析
title_fullStr 72例肺腺鳞癌临床病理特点和预后因素分析
title_full_unstemmed 72例肺腺鳞癌临床病理特点和预后因素分析
title_short 72例肺腺鳞癌临床病理特点和预后因素分析
title_sort 72例肺腺鳞癌临床病理特点和预后因素分析
topic 肺鳞癌专题
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973411/
https://www.ncbi.nlm.nih.gov/pubmed/27760593
http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.03
work_keys_str_mv AT 72lìfèixiànlínáilínchuángbìnglǐtèdiǎnhéyùhòuyīnsùfēnxī
AT 72lìfèixiànlínáilínchuángbìnglǐtèdiǎnhéyùhòuyīnsùfēnxī
AT 72lìfèixiànlínáilínchuángbìnglǐtèdiǎnhéyùhòuyīnsùfēnxī
AT 72lìfèixiànlínáilínchuángbìnglǐtèdiǎnhéyùhòuyīnsùfēnxī
AT 72lìfèixiànlínáilínchuángbìnglǐtèdiǎnhéyùhòuyīnsùfēnxī

Ejemplares similares